US 2002/0177574 A1 · Endometrial gene therapy

Abstract

A method for treating the uterus includes transfecting the uterus with a liposome-mediated gene. Hox genes have been found particularly relevant to diseases such as endometriosis, and manipulation of their expression can affect embryonic implantation.

Claims4

Dependent claims

A method for treating the uterus comprising transfecting the uterus with a liposome-mediated gene.

Dependencies are inferred from the claim text.

Facts

Application

10/127,219Filed 19 Apr 2002

Priority

20 Apr 2001

Published

28 Nov 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification4 codes

A61K 9/0034
Galenical forms characterised by the site of application: urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder;…
A61K 9/1272
Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers: comprising non-phosphatidyl surfactants as…
A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the
A61K
Medicines and medical preparations

Endometrial gene therapy

Life of this patent

Abstract

Claims4

Endometrial gene therapy

Life of this patent

Abstract

Claims4